CM Life Sciences II Inc. CMII
Trading inactive
| Name of reporting person | Citizenship or organization | Sole voting power | Shared voting power | Sole dispositive power | Shared dispositive power | Amount beneficially owned | Percent of class | Accepted date |
|---|---|---|---|---|---|---|---|---|
| ARK Investment Management LLC | Delaware, United States | 14241979 | 0 | 14241979 | 0 | 14241979 | 7.55 % | 29/01/2024 |
| BlackRock, Inc. | Delaware | 9970344 | 0 | 10268281 | 0 | 10268281 | 5.5 % | 03/02/2023 |
| Novartis Pharma AG | Switzerland | 0 | 8691140 | 0 | 8691140 | 8691140 | 4.8 % | 08/10/2021 |
| Novartis Institutes for BioMedical Research, Inc. | Delaware | 0 | 1676200 | 0 | 1676200 | 1676200 | 0.9 % | 08/10/2021 |
| Novartis AG | Switzerland | 0 | 10367340 | 0 | 10367340 | 10367340 | 5.7 % | 08/10/2021 |
| ARK Investment Management LLC | Delaware, United States | 2847175 | 0 | 2847175 | 0 | 2847175 | 10.32 % | 09/07/2021 |
| Gagnon Securities LLC | Delaware | 0 | 819920 | 0 | 876911 | 876911 | 3 % | 08/04/2021 |
| GAGNON ADVISORS, LLC | Delaware | 0 | 366905 | 0 | 366905 | 366905 | 0.1 % | 08/04/2021 |
| Neil Gagnon | USA | 134851 | 1257405 | 134851 | 1319839 | 1454690 | 5.3 % | 08/04/2021 |